Case study · Pharmaceuticals & biotech

Data and AI shorten a critical PAXLOVID manufacturing step at Pfizer

Pfizer needed to scale PAXLOVID production rapidly during the COVID-19 pandemic.

Manufacturer
Pfizer
Use cases
1
Evidence
Manufacturer-reported
Year
2023

Manufacturer-reported  This result comes from the manufacturer's own publications, such as newsroom posts, earnings materials or engineering blogs. It has not been independently verified.

The challenge

Pfizer needed to scale PAXLOVID production rapidly during the COVID-19 pandemic.

The approach

Pfizer teams analyzed supply chain and production data with AI to identify, address and monitor production issues, creating a continuous-improvement loop.

Reported improvements

Percent change as reported by the source; hover for the exact wording

Cycle time of a critical step↓ 67%

1 use case in this implementation

  1. Process & yield optimization

    AI analysis of supply chain and production data pinpointed and monitored bottlenecks in PAXLOVID manufacturing.

    • the cycle time of a critical step in the supply chain was able to be reduced by 67%
    • which enabled the production of 20,000 extra doses per batch

Outcomes as reported by the source. We do not adjust, combine or extrapolate reported figures.

Related case studies

Put AI to work

Find the AI opportunities hiding in your plant.

Genvo, our implementation partner, works with manufacturers to pick the right first project, connect the systems you already run and put AI agents and tools into daily use, with people approving what goes out.

Assessments and consultations are provided by Genvo. How our partnership works.